TY  - CHAP
M1  - Book, Section
TI  - Ventricular Arrhythmias and Sudden Cardiac Death
A1  - Hayase, Justin
A1  - Shivkumar, Kalyanam
A1  - Bradfield, Jason S.
A2  - Fuster, Valentin
A2  - Narula, Jagat
A2  - Vaishnava, Prashant
A2  - Leon, Martin B.
A2  - Callans, David J.
A2  - Rumsfeld, John S.
A2  - Poppas, Athena
PY  - 2022
T2  - Fuster and Hurst's The Heart, 15e
AB  - Chapter  SummaryThis  chapter  discusses  the  epidemiology  and  pathophysiology  of  sudden  cardiac  death  (SCD),  which  is  most  often  caused  by  ventricular  arrhythmias,  and  addresses  some  of  the  key  considerations  for  the  evaluation  and  treatment  of  ventricular  arrhythmias.  Major  risk  factors  for  developing  these  arrhythmias  include  cardiac  structural  abnormalities  and  coronary  artery  disease  (CAD)  (see  Fuster  and  Hurst’s  Central  Illustration).  Moreover,  a  number  of  inherited  channelopathies  can  predispose  to  these  arrhythmias  and  should  be  considered  in  the  context  of  a  structurally  normal  heart.  Ventricular  arrhythmias  can  range  from  idiopathic  premature  ventricular  complexes,  to  monomorphic  ventricular  tachycardia  (VT),  to  ventricular  fibrillation  (VF).  Management  of  ventricular  arrhythmias  requires  a  comprehensive  approach  that  may  involve  multiple  therapies,  including  an  implantable  cardioverter  defibrillator  (ICD),  antiarrhythmic  medications,  catheter  ablation,  and/or  autonomic  modulation.  The  decision-making  process  for  management  depends  highly  upon  the  presence  of  underlying  structural  abnormalities.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1202447458
ER  -